HUP0103544A3 - Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation - Google Patents

Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation

Info

Publication number
HUP0103544A3
HUP0103544A3 HU0103544A HUP0103544A HUP0103544A3 HU P0103544 A3 HUP0103544 A3 HU P0103544A3 HU 0103544 A HU0103544 A HU 0103544A HU P0103544 A HUP0103544 A HU P0103544A HU P0103544 A3 HUP0103544 A3 HU P0103544A3
Authority
HU
Hungary
Prior art keywords
dicyklobutylamino
hidrogen
paroxetin
benzopyran
carboxamide
Prior art date
Application number
HU0103544A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0103544A2 publication Critical patent/HUP0103544A2/hu
Publication of HUP0103544A3 publication Critical patent/HUP0103544A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
HU0103544A 1998-09-16 1999-09-13 Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation HUP0103544A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803156A SE9803156D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (2)

Publication Number Publication Date
HUP0103544A2 HUP0103544A2 (hu) 2002-05-29
HUP0103544A3 true HUP0103544A3 (en) 2003-12-29

Family

ID=20412627

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103544A HUP0103544A3 (en) 1998-09-16 1999-09-13 Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation

Country Status (21)

Country Link
EP (1) EP1128825A1 (hu)
JP (1) JP2002524508A (hu)
KR (1) KR20010099647A (hu)
CN (1) CN1317964A (hu)
AR (1) AR021808A1 (hu)
AU (1) AU6378099A (hu)
BR (1) BR9913748A (hu)
CA (1) CA2342341A1 (hu)
CZ (1) CZ2001961A3 (hu)
EE (1) EE200100157A (hu)
HU (1) HUP0103544A3 (hu)
ID (1) ID28785A (hu)
IL (1) IL141519A0 (hu)
IS (1) IS5879A (hu)
NO (1) NO20011312L (hu)
PL (1) PL346763A1 (hu)
SE (1) SE9803156D0 (hu)
SK (1) SK3262001A3 (hu)
TR (1) TR200100779T2 (hu)
WO (1) WO2000015218A1 (hu)
ZA (1) ZA200101946B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
US20090036488A1 (en) * 2005-03-04 2009-02-05 Tokyo Medical And Dental University Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
IL141519A0 (en) 2002-03-10
AR021808A1 (es) 2002-08-07
NO20011312D0 (no) 2001-03-15
EP1128825A1 (en) 2001-09-05
WO2000015218A1 (en) 2000-03-23
SE9803156D0 (sv) 1998-09-16
SK3262001A3 (en) 2001-08-06
CZ2001961A3 (cs) 2001-08-15
JP2002524508A (ja) 2002-08-06
AU6378099A (en) 2000-04-03
HUP0103544A2 (hu) 2002-05-29
KR20010099647A (ko) 2001-11-09
CA2342341A1 (en) 2000-03-23
PL346763A1 (en) 2002-02-25
EE200100157A (et) 2002-08-15
IS5879A (is) 2001-03-07
ZA200101946B (en) 2002-06-10
CN1317964A (zh) 2001-10-17
TR200100779T2 (tr) 2001-10-22
NO20011312L (no) 2001-05-16
ID28785A (id) 2001-07-05
BR9913748A (pt) 2001-07-10

Similar Documents

Publication Publication Date Title
HUP0203257A3 (en) Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP0103082A2 (en) Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
HK1022835A1 (en) Pharmaceutical composition for treatment of diabetes
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0401619A3 (en) Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them
HUP0301842A3 (en) Lactam compound, pharmaceutical composition containing it and use of it for producing pharmaceutical composition
HUP0200396A3 (en) Gluckokinase activators, process for their preparation, pharmaceutical compositions containing them and their use
HUP0103333A3 (en) Pyrroloindoles, pyridoindoles and azepinoindiles as 5-ht2c agonists, process for their preparation and pharmaceutical compositions containing them
HUP0103404A3 (en) Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0102334A3 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing the compound
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物
HU0100489D0 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
EG22344A (en) Process for preparing of novel pharmaceutical composition
HUP0002724A3 (en) Clasto-lactacystin betha-lactone, analogs and intermediates thereof, process for their preparation and pharmaceutical compositions containing them
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
EE03874B1 (et) (R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis
HUP9902784A3 (en) Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them
HUP0103544A3 (en) Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation
PL360090A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
HUP0104202A3 (en) Thiazole-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9702227A3 (en) New benzopirane compounds, process for producing them and pharmaceutical composition containing them